JAMA Pediatrics

JAMA Pediatrics JAMA Pediatrics is a member of the JAMA Network, a consortium of peer-reviewed publications.

Exposure to alcohol-promoting content increased desire to drink among young adults, supporting concerns about online i...
02/25/2026

Exposure to alcohol-promoting content increased desire to drink among young adults, supporting concerns about online influencer content and its influence on alcohol-related attitudes.

https://ja.ma/4cal0A0

đź“„ This JAMA Pediatrics Patient Page describes how new guidance aiming to improve reporting of clinical trials may help y...
02/25/2026

đź“„ This JAMA Pediatrics Patient Page describes how new guidance aiming to improve reporting of clinical trials may help young people and parents find information to make the right health care decisions for them.

https://ja.ma/4rGbv0c

SPIRIT–Children and Adolescents (SPIRIT-C) 2026 is a pediatric-focused extension of the SPIRIT 2025 guideline developed ...
02/25/2026

SPIRIT–Children and Adolescents (SPIRIT-C) 2026 is a pediatric-focused extension of the SPIRIT 2025 guideline developed to improve the reporting quality and completeness of randomized controlled trial protocols involving patients aged 0 to 19 years.

https://ja.ma/46qdT2E

The CONSORT–Children and Adolescents (CONSORT-C) 2026 guideline extends CONSORT 2025 with 13 new reporting items for ped...
02/25/2026

The CONSORT–Children and Adolescents (CONSORT-C) 2026 guideline extends CONSORT 2025 with 13 new reporting items for pediatric RCTs, enhancing transparency, reproducibility, and relevance for patients aged 0 to 19 years.

https://ja.ma/46syN0Z

Well-reported clinical trials are essential to patients’ evidence-informed health care decisions.📄 This JAMA Pediatrics ...
02/25/2026

Well-reported clinical trials are essential to patients’ evidence-informed health care decisions.

đź“„ This JAMA Pediatrics Patient Page describes how new guidance aiming to improve reporting of clinical trials may help young people and parents find information to make the right health care decisions for them.

https://ja.ma/46og5aN

đź’¬ Editor's Note from JAMA Pediatrics Editor in Chief Dimitri A. Christakis, MD, MPH: The new CONSORT-C and SPIRIT-C guid...
02/25/2026

đź’¬ Editor's Note from JAMA Pediatrics Editor in Chief Dimitri A. Christakis, MD, MPH: The new CONSORT-C and SPIRIT-C guidelines mark a pivotal advance in pediatric research by establishing standards that reflect the unique needs of children.

These guidelines will guide modifications to research protocols and reporting for pediatric clinical trials and are expected to become standard for researchers publishing in this field.

The use of pediatric-specific reporting guidance will enhance the clarity, transparency, and reliability of clinical trial evidence for young populations.

https://ja.ma/4qSIhdl

SPIRIT–Children and Adolescents (SPIRIT-C) 2026 is a pediatric-focused extension of the SPIRIT 2025 guideline developed ...
02/24/2026

SPIRIT–Children and Adolescents (SPIRIT-C) 2026 is a pediatric-focused extension of the SPIRIT 2025 guideline developed to improve the reporting quality and completeness of randomized controlled trial protocols involving patients aged 0 to 19 years.

SPIRIT-C 2026 introduces 17 new recommended reporting items—shaped by input from young people and family caregivers—to ensure trial protocols address key pediatric-specific considerations, such as age-appropriate interventions, procedural pain minimization, and developmental relevance of outcomes.

Adoption of SPIRIT-C 2026 can foster the preparation of comprehensive and transparent pediatric trial protocols, strengthen the evidence base, and reduce research waste.

https://ja.ma/4tPIAIp

The CONSORT–Children and Adolescents (CONSORT-C) 2026 guideline is an extension of the CONSORT 2025 statement, designed ...
02/24/2026

The CONSORT–Children and Adolescents (CONSORT-C) 2026 guideline is an extension of the CONSORT 2025 statement, designed to improve the reporting quality and completeness of pediatric randomized controlled trials involving patients aged 0 to 19 years.

Developed with input from young people and family caregivers, CONSORT-C 2026 includes 13 additional items that reflect the priorities of clinicians, researchers, and families.

Widespread adoption of this guideline may enhance transparency and reproducibility, support critical appraisal and synthesis of trial findings, and minimize research waste in pediatric studies.

https://ja.ma/3OmHGTN

Assigned female at birth youth in Medicaid and CHIP had higher rates of hormone therapy and puberty blocker use than ass...
02/24/2026

Assigned female at birth youth in Medicaid and CHIP had higher rates of hormone therapy and puberty blocker use than assigned male at birth youth, with lower overall gender-related care utilization compared to commercially insured adolescents.

https://ja.ma/4awf3Mv

From JAMA: virus newborn vaccination rates in the US peaked at 83% in early 2023 but dropped to 73% by August 2025, co...
02/24/2026

From JAMA:

virus newborn vaccination rates in the US peaked at 83% in early 2023 but dropped to 73% by August 2025, coinciding with increased public discourse regarding childhood vaccination.

https://ja.ma/4tTHn2M

From JAMA: Newborn virus vaccination rates in the US increased from approximately 67% in 2017 to 83% in early 2023, bu...
02/24/2026

From JAMA: Newborn virus vaccination rates in the US increased from approximately 67% in 2017 to 83% in early 2023, but recently declined to 73% by August 2025, according to large-scale electronic health records.

The decrease coincided with intensified public discourse and media coverage regarding childhood vaccination after July 2023.

https://ja.ma/4qPtXSG

In young children with acute wheezing, using a higher drug-delivery valved holding chamber improved respiratory distress...
02/23/2026

In young children with acute wheezing, using a higher drug-delivery valved holding chamber improved respiratory distress and lowered hospitalization rates, highlighting device selection as important for inhalation therapy.

https://ja.ma/4awzx7L

Address

330 N Wabash Avenue
Chicago, IL
60611

Telephone

+13126707827

Website

Alerts

Be the first to know and let us send you an email when JAMA Pediatrics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category